In a seminal study, Collins et al. [25] showed that, in patients with hypoparathyroidism or pseudohypoparathyroidism, calcitriol therapy not only elevates serum vitamin D levels, but also increases serum FGF-23 levels. This evidence concerns the gene FGF23 and pseudohypoparathyroidism type 1A.